Cargando…
Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828385/ https://www.ncbi.nlm.nih.gov/pubmed/35150883 http://dx.doi.org/10.1016/j.cmi.2022.01.028 |
| _version_ | 1784647833330122752 |
|---|---|
| author | Macías, Juan Fernández-Fuertes, Marta Oliver, Noemí Corma-Gómez, Anaïs Real, Luis M. Pineda, Juan A. |
| author_facet | Macías, Juan Fernández-Fuertes, Marta Oliver, Noemí Corma-Gómez, Anaïs Real, Luis M. Pineda, Juan A. |
| author_sort | Macías, Juan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8828385 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88283852022-02-10 Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV Macías, Juan Fernández-Fuertes, Marta Oliver, Noemí Corma-Gómez, Anaïs Real, Luis M. Pineda, Juan A. Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-05 2022-02-10 /pmc/articles/PMC8828385/ /pubmed/35150883 http://dx.doi.org/10.1016/j.cmi.2022.01.028 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Macías, Juan Fernández-Fuertes, Marta Oliver, Noemí Corma-Gómez, Anaïs Real, Luis M. Pineda, Juan A. Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV |
| title | Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV |
| title_full | Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV |
| title_fullStr | Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV |
| title_full_unstemmed | Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV |
| title_short | Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV |
| title_sort | lower probability of persistence of total anti-sars-cov-2 antibodies after covid-19 among people living with hiv |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828385/ https://www.ncbi.nlm.nih.gov/pubmed/35150883 http://dx.doi.org/10.1016/j.cmi.2022.01.028 |
| work_keys_str_mv | AT maciasjuan lowerprobabilityofpersistenceoftotalantisarscov2antibodiesaftercovid19amongpeoplelivingwithhiv AT fernandezfuertesmarta lowerprobabilityofpersistenceoftotalantisarscov2antibodiesaftercovid19amongpeoplelivingwithhiv AT olivernoemi lowerprobabilityofpersistenceoftotalantisarscov2antibodiesaftercovid19amongpeoplelivingwithhiv AT cormagomezanais lowerprobabilityofpersistenceoftotalantisarscov2antibodiesaftercovid19amongpeoplelivingwithhiv AT realluism lowerprobabilityofpersistenceoftotalantisarscov2antibodiesaftercovid19amongpeoplelivingwithhiv AT pinedajuana lowerprobabilityofpersistenceoftotalantisarscov2antibodiesaftercovid19amongpeoplelivingwithhiv |